4P-Pharma, a recognized actor in the ADHD drug pipeline development

4P-Pharma is a recognized actor in the ADHD pipeline drug development.

Stimulant abuse and addiction is surging and is becoming a major global health problem. Recently, the CDC released worrisome data on psychostimulants-related overdose death, with a 33,3% increase from 2015-2016*. Last April, at the National Rx Drug Abuse and Heroin Summit, experts warned of a fast-growing and significant stimulant epidemic. 4P-003 is our innovative product developed as a novel deterrent approach for stimulant misuse, under a 505(b)2 approval.

 

 

 

 

*U.S. drug overdose deaths continue to rise; increase fueled by synthetic opioids. Center for Diseases Control and Prevention, Press Release, March 29, 2018.